Sanara MedTech Inc. SMTI Finite-Lived Intangible Assets - Expected Amortization Expense (Year Five)
Finite-Lived Intangible Assets - Expected Amortization Expense (Year Five) at other companies
Other financials
Where this comes from
Reported directly by Sanara MedTech Inc. in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive.
The official record: Sanara MedTech Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sanara MedTech Inc.'s finite-lived intangible assets - expected amortization expense (year five).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sanara MedTech Inc.'s finite-lived intangible assets - expected amortization expense (year five)?
- Sanara MedTech Inc. (SMTI) reported finite-lived intangible assets - expected amortization expense (year five) of $7.07M in Q1 2026.
- How has Sanara MedTech Inc.'s finite-lived intangible assets - expected amortization expense (year five) changed year-over-year?
- Sanara MedTech Inc.'s finite-lived intangible assets - expected amortization expense (year five) decreased by 64.4% year-over-year, from $19.85M to $7.07M.
- What is the long-term trend for Sanara MedTech Inc.'s finite-lived intangible assets - expected amortization expense (year five)?
- Over 4 years (2021 to 2025), Sanara MedTech Inc.'s finite-lived intangible assets - expected amortization expense (year five) has grown at a 34.9% compound annual growth rate (CAGR), from $2.56M to $8.49M.
- What does finite-lived intangible assets - expected amortization expense (year five) mean?
- This represents the projected amortization expense for intangible assets with finite useful lives in the fifth year following the current reporting period. It provides visibility into the long-term impact of capitalized acquisition costs on future earnings. This metric is essential for modeling long-term profitability and assessing the duration of competitive advantages derived from acquired assets.